Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
Managing Congenital Adrenal Hyperplasia in the Amish Population
Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...